Globus Medical, Inc. (GMED) belonging to the Healthcare sector has surged 0.04% and closed its last trading session at $48.24.
The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $45.33.
The consensus recommendation, according to Zacks Investment research, is 2. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.17 and 2.33 respectively.
Globus Medical, Inc. on 9/29/2017 reported its EPS as $0.31 with the analysts projecting the EPS of the stock as $0.33. The company beat the analyst EPS Estimate with the difference of $-0.02. This shows a surprise factor of -0.061%.
Many analysts have provided their estimated foresights on Globus Medical, Inc. Earnings, with 12 analysts believing the company would generate an Average Estimate of $0.35.
Whereas they predicted High and Low Earnings Estimate as $0.36 and $0.33 respectively. While in the same Quarter Previous year, the Actual EPS was $0.31.
Analysts are also projecting an Average Revenue Estimate for Globus Medical, Inc. as $166530 in the Current Quarter. This estimate is provided by 11 analysts.
The High Revenue estimate is predicted as 175500, while the Low Revenue Estimate prediction stands at 163000. The company’s last year sales total was 151590.
For the Current Quarter, the growth estimate for Globus Medical, Inc. is 12.9%, while for the Next Quarter the stock growth estimate is 9.4%.
In the past 5 years, the stock showed growth of 10.29% per annum. While for the next 5 years, the growth estimate is 10.45%.
Globus Medical, Inc. (GMED) has the market capitalization of $4.55 Billion. The company rocked its 52-Week High of $48.63 and touched its 52-Week Low of $26.95.
The stock has Return on Assets (ROA) of 10.9 percent. Return on Equity (ROE) stands at 12.1% and Return on Investment (ROI) of 12.2 percent.
The stock is currently showing YTD performance of 17.37 Percent. The company has Beta Value of 0.46 and ATR value of 1.18. The Weekly and Monthly Volatility stands at 2.59% and 2.61%.